Clinical Trials Directory

Trials / Completed

CompletedNCT03500588

Vascular Endothelial Factor Gene Polymorphism in Preeclampsia

Vascular Endothelial Growth Factor C/A 2578 Gene Polymorphism and Umbilical Artery Doppler in Preeclamptic Women

Status
Completed
Phase
Study type
Observational
Enrollment
290 (actual)
Sponsor
Beni-Suef University · Academic / Other
Sex
Female
Age
18 Years – 45 Years
Healthy volunteers
Not accepted

Summary

In this study, the investigators assessed one of the released protein factors during the pathophysiology of preeclampsia. They evaluated vascular endothelial growth factor gene mutation which affects the angiogenesis in case of inadequate placentation and its association with Doppler changes in the pulsatility index of the umbilical artery.

Detailed description

Preeclampsia is a syndrome characterized by occurrence of hypertension and proteinuria after 20 weeks of gestation. The pathophysiology of preeclampsia involves abnormalities in the development of placental vasculature early in pregnancy may result in relative placental under perfusion/hypoxia/ischemia, which then leads to release of factors into the maternal circulation that alter maternal endothelial function and cause hypertension and other manifestations of disease .Vascular endothelial growth factor (VEGF) is a signal protein produced by cells that stimulates vasculogenesis and angiogenesis. It is part of the system that restores the oxygen supply to tissues when blood circulation is inadequate. Human VEGF gene is located on chromosome 6 and consists of 8 exons with alternate splicing, forming a family of proteins. There are several common single nucleotide polymorphisms (SNPs) in the VEGF gene, which could alter gene expression and protein production, and alter the risk of developing diseases characterized by deranged angiogenesis including preeclampsia.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTPCRPolymerase chain reaction was used to diagnose gene polymorphism.
DEVICEDoppler ultrasoundDoppler ultrasound was used to assess the pulsatility index of the umbilical artery .

Timeline

Start date
2017-01-01
Primary completion
2018-01-01
Completion
2018-02-01
First posted
2018-04-18
Last updated
2021-03-26

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT03500588. Inclusion in this directory is not an endorsement.